Seqirus - Immunohaematology Business Unit's Unit Acquisition

Seqirus - Immunohaematology Business Unit raised a round of funding on December 05, 2017. Investors include Paragon Care.

Seqirus is an influenza vaccine company with research and production capabilities and manufacturing plants in the US, UK, Germany and Australia.…

Articles about Seqirus - Immunohaematology Business Unit's Unit Acquisition: